Document ID: chunk:federal_register_of_legislation:F2024L01524:schedule:1:p11
Version: federal_register_of_legislation:F2024L01524
Segment Type: schedule
Provision Reference: sch 1 (pt 11/38)
Character Range: 28708–31751

Repeats: 5]
insert:
Rizatriptan  Tablet (orally disintegrating) 10 mg (as benzoate)  Oral  APO-RIZATRIPTAN ODT  TW  MP NP  C5708     4  5     2

[77] Schedule 1, Part 1, entry for Testosterone in the form Transdermal cream 50 mg per mL, 50 mL [Maximum Quantity: 1; Number of Repeats: 1]
(a) omit from the column headed "Circumstances": C11838 C11891 C11947 C11962 C11963  substitute: C16166 C16194 C16204 C16211 C16212
(b) omit from the column headed "Purposes": P11838 P11891 P11947 P11962 P11963  substitute: P16166 P16194 P16204 P16211 P16212
[78] Schedule 1, Part 1, entry for Testosterone in the form Transdermal cream 50 mg per mL, 50 mL [Maximum Quantity: 2; Number of Repeats: 1]
(a) omit from the column headed "Circumstances": C15622 C15623 C15654 C15739 C15756  substitute: C16186 C16195 C16206 C16207 C16214
(b) omit from the column headed "Purposes": P15622 P15623 P15654 P15739 P15756  substitute: P16186 P16195 P16206 P16207 P16214
[79] Schedule 1, Part 1, entry for Upadacitinib in the form Tablet 15 mg [Maximum Quantity: 28; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14696
(b) omit from the column headed "Purposes": P14696
[80] Schedule 1, Part 1, entry for Upadacitinib in the form Tablet 30 mg [Maximum Quantity: 28; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14696
(b) omit from the column headed "Purposes": P14696
[81] Schedule 1, Part 1, entry for Upadacitinib in the form Tablet 45 mg [Maximum Quantity: 28; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C14696
(b) omit from the column headed "Purposes": P14696
[82] Schedule 1, Part 1, entries for Vancomycin
omit:
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Alphapharm  AF  MP   C5717        P5717        2  0     1
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Alphapharm  AF  PDP  C5801        P5801        2  0     1
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Alphapharm  AF  MP   C5716 C5769  P5716 P5769  5  0     1
Vancomycin  Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride)   Injection  Vancomycin Alphapharm  AF  MP   C5717        P5717        1  0     1
Vancomycin  Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride)   Injection  Vancomycin Alphapharm  AF  PDP  C5801        P5801        1  0     1
Vancomycin  Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride)   Injection  Vancomycin Alphapharm  AF  MP   C5716 C5769  P5716 P5769  3  0     1

[83] Schedule 1, Part 1, after entry for Vancomycin in the form Capsule 250 mg (250,000 I.U.) (as hydrochloride) [Brand: Vancomycin BNM 250mg]
insert:
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  MP   C5717        P5717        2  0     1
Vancomycin  Powder for injection 500 mg (500,000 I.U.) (as hydrochloride)  Injection  Vancomycin Viatris  AL  PDP  C5801        P5801